Skip to main content

XERS

Xeris Biopharma Holdings, Inc.

Company with tickers: XERS

CIK
1867096
CUSIP
98422E103
Shares Outstanding
172,642,055
13F Activity (30d)
3 filings 2 filers

Notices of intent to sell restricted or control shares, filed with the SEC on Form 144 by insiders and affiliates. A Form 144 signals a planned sale — it does not confirm the shares were actually sold.

Filed Seller Shares
2026-06-04 JOHN H JOHNSON 15,000
2026-06-04 DAWN HALKUFF 20,000
2026-06-04 Barbara-Jean Bormann-Kennedy 16,000
2026-06-03 MARLA PERSKY 15,500
2026-03-30 JAMES BRADY 10,834
2026-03-02 BETH HECHT 66,668
2026-01-08 KEVIN MCCULLOCH 60,000
2025-12-19 JOHN H JOHNSON 135,402
2025-12-12 BARBARA-JEAN A BORMANN-KENNEDY 15,000
2025-11-13 JOHN SHANNON 48,149
2025-11-12 BETH HECHT 66,668
2025-09-11 MARLA PERSKY 15,500
2025-08-28 JEFFREY SHERMAN 42,232
2025-08-13 JOHN H JOHNSON 107,500
2025-08-12 DAWN HALKUFF 42,500
2025-05-09 Fairley Ricki Louise 56,667
2025-03-20 Hecht Beth 40,000
Showing 1–17 of 17 filings